搜索筛选:
搜索耗时0.1031秒,为你在为你在102,285,761篇论文里面共找到 8 篇相符的论文内容
类      型:
[期刊论文] 作者:Chia-Chang Chen,Hong-Zen Yeh,C, 来源:世界胃肠病学杂志:英文版(电子版) 年份:2013
This paper introduces an innovative treatment for extrahepatic metastasis of hepatocellular carcinoma. A 71-yearold patient had a stable liver condition followi...
[期刊论文] 作者:Shou-Wu Lee,Teng-Yu Lee,Hong-Zen Yeh,Chun-Fang Tung,Yen-Chun Peng,, 来源:World Journal of Gastroenterology 年份:2010
AIM:To assess the risk factors and the eff icacy of medications of patients with gastric and duodenal ulcers among Chinese patients in Taiwan.METHODS:Patients w...
[会议论文] 作者:Cheng-Chan Yu,Hong-Zen Yeh,Jen-I Hwang,Cheng-Chung Wu,Shao-Bing Cheng, 来源:第十二届国际胃癌学术会议 年份:2017
[期刊论文] 作者:Shou-Wu Lee,Teng-Yu Lee,Sheng-Shun Yang,Yen-Chun Peng,Hong-Zen Yeh,Chi-Sen Chang,, 来源:Hepatobiliary & Pancreatic Diseases International 年份:2017
BACKGROUND: Non-alcoholic fatty liver disease(NAFLD) is associated with features of metabolic syndrome. The aim of this study was to investigate the association...
[期刊论文] 作者:Shou-Wu Lee,Chi-Sen Chang,Teng-Yu Lee,Hong-Zen Yeh,Chun-Fang Tung,Yen-Chun Peng, 来源:世界胃肠病学杂志(英文版) 年份:2010
AIM: To assess the risk factors and the efficacy of medications of patients with gastric and duodenal ulcers among Chinese patients in Taiwan.METHODS: Patients...
[期刊论文] 作者:Chia-Chang Chen,Hong-Zen Yeh,Chi-Sen Chang,ChungWang Ko,Han-Chung Lien,Chun-Ying Wu,Siu-Wan Hung,, 来源:World Journal of Gastroenterology 年份:2013
This paper introduces an innovative treatment for extrahepatic metastasis of hepatocellular carcinoma. A 71-yearold patient had a stable liver condition followi...
[期刊论文] 作者:Wan-Tzu Lin,Yi-Jun Liao,Yen-Chun Peng,Chung-Hsin Chang,Ching-Heng Lin,Hong-Zen Yeh,Chi-Sen Chang,, 来源:World Journal of Gastroenterology 年份:2017
AIM To investigate the relationship between selective serotonin reuptake inhibitor(SSRI)use and the subsequent development of irritable bowel syndrome(IBS).METH...
[期刊论文] 作者:Chang,Po-Huang Lee,Deng-Yn Lin,Cheng-Chung Wu,Long-Bin Jeng,Yih-Jyh Lin,King-Tong Mok,Wei-Chen Lee,Hong-Zen Yeh, 来源:World Journal of Gastroenterology 年份:2014
AIM: To demonstrate that administering heparanase inhibitor PI-88 at 160 mg/d is safe and promising in reducing hepatocellular carcinoma(HCC) recurrence for up...
相关搜索: